Search This Blog

Wednesday, July 25, 2018

BioTelemetry reports Q2 adj. EPS 46c, consensus 31c


Reports Q2 revenue $101.4M, consensus $95.86M. This increase was attributable to the addition of LifeWatch, the organic revenue growth and synergies gained from the integration of LifeWatch.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.